Clinical Trial Update: A Study of CM512 in Subjects With Moderate-to-Severe Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for CM512 in adults with moderate-to-severe chronic obstructive pulmonary disease, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CM512

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: NOT_YET_RECRUITING